The National Bleeding Disorders Foundation (NBDF) has announced the recipients of its 2025 research grant cycle, providing new research funding through its the Judith Graham Pool Postdoctoral Research Fellowship, Excellence Fellowships in…
#bdbody {
width: 80%;
margin: 0 auto;
padding: 1rem;
}
/* Mobile and tablet: 100% width */
@media (max-width: 991px) {
#bdbody {
width: 100%;
padding: 1rem; /* optional padding for small screens…
After decades of research during which gene therapy was considered a distant goal, FDA-approved gene therapy options for hemophilia are now available in the United States. As these therapies enter real-world clinical practice, patients and care…
The National Bleeding Disorders Foundation (NBDF) offers multiple funding opportunities for bleeding disorders researchers across all career stages and disciplines. Through the Judith Graham Pool Postdoctoral Research Fellowships,…
The National Bleeding Disorders Foundation (NBDF) is launching Educate to Elevate, a multi-year initiative to raise public awareness, educate communities, and improve healthcare access for individuals with bleeding disorders. The campaign…
Oradora: Daisy Cortes, MDEsta terapia de reequilibrio ofrece un tratamiento subcutáneo para personas que viven con hemofilia A o B. Sanofi le invita a participar en una presentación educativa, donde un médico compartirá información…
CHAPTER 1 Recommendation on the Use and Management of Antithrombin Inhibitor EXPERTS: Magdalena D Lewandowska MD 1, Janice Staber MD2, Amy Dunn MD on behalf of MASAC 1(Innovative Hematology, Indiana…
Since 2009, Dr. Branchford has been a hematology/oncology/bone marrow transplant fellow at the Children's Hospital of Denver. Prior to this post, he served as Chief Resident at the Children's Hospital of Wisconsin-Milwawukee. Dr. Branchford received…
Speakers: Hilda Ding, MD, MS, Medical Director, Hemophilia & Thrombosis Treatment Center, Rady Children's Hospital San DiegoDescription: Join Takeda expert Dr. Ding for an interactive discussion, sharing the…